Diskussionsleiter: F. Cuello (Hamburg)
| (BS64) | Regulated BNP secretion in ventricular cardiomyocytes | |
| K. Zhang, K. Mhatre, P. Wakula-Heinzel, B. Pieske, F. R. Heinzel (Berlin) | ||
| (BS65) | Levosimendan protects against anoxia/reoxygenation-mediated cell death in H9c2 myoblasts | |
| A. Schauer, D. M. Poitz, P. Barthel, R. H. Strasser, C. Weinbrenner (Dresden, Hanau) | ||
| (BS66) | MicroRNA miR-29 promotes pathologic remodeling of the heart by activating Wnt cascades in cardiac myocytes | |
| Y. Sassi, P. Avramopoulos, D. Ramanujam, L. Grüter, S. Werfel, S. Giosele, A.-D. Brunner, D. Esfandyari, A. S. Papadopoulou, B. de Strooper, R. Kumarswamy, T. Thum, X. Yin, M. Mayr, B. Laggerbauer, S. Engelhardt (München, Hannover; Leuven, BE; London, UK) | ||
| (BS67) | Cardiomyocyte calcium dysregulation in a metabolic risk factor based model of heart failure with preserved ejection fraction |
|
| U. Primessnig, F. Hohendanner, D. Bode, T. Guthof, B. Pieske, F. R. Heinzel (Berlin) | ||
| (BS68) | Role of angiotensin II in FGF23 induced Ca2+ signaling in cardiac hypertrophy | |
| K. Mhatre, P. Wakula-Heinzel, B. Pieske, F. R. Heinzel (Berlin) | ||
| (BS69) | Empagliflozin potently reduces sarcoplasmic reticulum Ca leak and CaMKII activity in isolated human and murine cardiomyocytes | |
| O. Wagemann, J. Mustroph, S. Lebek, K. Pichler, L. S. Maier, S. Wagner (Regensburg) |